Skip to main content
. 2022 May 6;10(5):728. doi: 10.3390/vaccines10050728

Table 4.

Comparison of antibody level and antibody level/cut-off between groups with different diagnoses.

Variables Diagnosis p
LSIL (CIN 1)
n = 18
HSIL (CIN 2, CIN 3)
and cancer
n = 36
Antibody level (M ± SD) 1.63 ± 0.88 1.53 ± 0.89 0.691
Antibody level/cut-off (M ± SD) 5.39 ± 2.90 5.04 ± 2.92 0.691

pp-value; LSIL—low-grade squamous intraepithelial lesion; HSIL—high-grade squamous intraepithelial lesion; n—number.